Myelin-reactive T cells and their regulation in multiple sclerosis

Michael K. Racke, Amy E. Lovett-Racke, Nitin J. Karandikar, S. Brian Wilson, Nancy L. Monsons

Research output: Contribution to journalReview articlepeer-review


Although the cause of multiple sclerosis (MS) is unknown, advances in brain imaging, immunology and molecular biology have increased researchers' understanding of this disease. Several therapies are currently being used to treat MS, but no single therapy has demonstrated dramatic treatment efficacy, so the need for improved therapies remains. There is growing evidence that immune responses directed against myelin antigens plays a role in the pathogenesis of MS. Evidence also exists for the presence of immune cells which may regulate autoreactive cells present in both healthy individuals and MS patients. As knowledge in the area of T cell biology in MS grows, it is to be expected that useful and interpretable data will be obtained for the development of new, improved therapeutic regimens for MS. These results are eagerly anticipated.

Original languageEnglish (US)
Pages (from-to)31-40
Number of pages10
JournalNeuroScience News
Issue number4-5
StatePublished - Dec 1 2001


  • Costimulation
  • Immunology
  • Multiple sclerosis
  • NK T cell
  • T cell

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Myelin-reactive T cells and their regulation in multiple sclerosis'. Together they form a unique fingerprint.

Cite this